Measurement of urinary iodine for the post-operative patients of differentiated thyroid carcinoma

Measurement of urinary iodine for the post-operative patients of differentiated thyroid carcinoma - Measurement of urinary iodine for the patients of thyroid carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019584

Enrollment

Registered

2016-01-01

Start date

2013-06-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

method of restriction in iodine-intake: A, method of stimulating TSH: A (method of restriction in iodine-intake: A:self-control B:use of packed low-iodine diet method of stimulating TSH: A: withdra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The post-operative patients with differentiated tyroid carcinoma who consent to this study in writing and undergo I-131 therapy.

Exclusion criteria

Exclusion criteria: The patients whose urine sample are not able to taken, and the patients who are not able to take meals.

Design outcomes

Primary

Measure	Time frame
We assess the outcome with the I-131 scintigraphy and serum thyroglobulin level 6 to 8 months after the I-131 therapy.	—

Countries

Japan

Contacts

Public ContactShinji Ito

Nagoya University Hospital Department of Radiology

itoshj@med.nagoya-u.ac.jp052-744-2327

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026